VENOMYX THERAPEUTICS


We are developing the next generation of antitoxin therapeutics beginning with the world's first universal antivenom.

 

SCROLL DOWN

VENOMYX THERAPEUTICS


We are developing the next generation of antitoxin therapeutics beginning with the world's first universal antivenom.

 

 
In 2018, over 5 million people around the world will be bitten by a venomous snake.150,000 of them will die and 500,000 will be permanently disabled.
The World Health Organization has identified the unavailability of effective snake antivenom to be a critical health issue at a global level.